Patents by Inventor Fatima Teixeira Clerc

Fatima Teixeira Clerc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
    Patent number: 8575125
    Abstract: The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: November 5, 2013
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
    Publication number: 20120277296
    Abstract: The present invention relates to selective CB2 agonists for use in the prevention or treatment of alcoholic liver disease and particularly alcoholic hepatic steatosis and liver inflammation, and pharmaceutical composition thereof.
    Type: Application
    Filed: July 21, 2010
    Publication date: November 1, 2012
    Inventors: Sophie Lotersztajn, Fatima Teixeira-Clerc, Arlane Mallat, Alexandre Louvet
  • SELECTIVE INHIBITORS OF CB2 RECEPTOR EXPRESSION AND/OR ACTIVITY FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
    Publication number: 20120115931
    Abstract: The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 10, 2012
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
    Patent number: 8084422
    Abstract: The invention relates to the use of a selective inhibitor of CB2 receptor expression and/or for the manufacture of a medicament indented for the treatment and/or the prevention of obesity and obesity-related disorders.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 27, 2011
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Sylvie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu
  • SELECTIVE INHIBITORS OF CB2 RECEPTOR EXPRESSION AND/OR ACTIVITY FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
    Publication number: 20100056758
    Abstract: The invention relates to the use of a selective inhibitor of CB2 receptor expression and/or for the manufacture of a medicament indented for the treatment and/or the prevention of obesity and obesity-related disorders.
    Type: Application
    Filed: April 4, 2008
    Publication date: March 4, 2010
    Inventors: Vanessa Deveaux, Fatima Teixeira Clerc, Syivie Manin, Sophie Lotersztajn, Ariane Mallat, Jeanne Tran-Van-Nhieu